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Abstract
Background: Imbalanced autonomic nervous system (ANS) activity is associated with poor cardiovascular outcome.
However, clinically validated biomarkers to assess parasympathetic function are not yet available. We sought to
evaluate parasympathetic dysfunction by measuring serum cholinesterase activity and to determine its relationship
to high sensitive cardiac troponin T (hs-cTnT) as well as traditional non-invasive parameters of ANS function during
exercise in apparently healthy individuals.
Methods: We enrolled 1526 individuals (mean age 49 ± 11 yr., 75% men) from the Tel Aviv Medical Center Inflammation
Survey (TAMCIS). We used the acetylcholine (ACh) analog acetylthiocholine (ATCh) as a substrate that is hydrolyzed by
both ACh degrading enzymes and reflects the total serum capacity for acetylcholine hydrolysis, referred to as cholinergic
status (CS). All subjects performed a cardiac stress test reviewed on the spot by a cardiologist and multiple physiological
and metabolic parameters including hs-cTnT were measured.
Results: CS values at rest predicted multiple exercise-hemodynamic changes. Heart rate recovery after exercise was
inversely correlated to CS values (p < 0.01 and p = 0.03 for women and men respectively), and a hypertensive reaction
during exercise was associated with elevated CS levels in women. Most importantly, women with detectable hs-cTnT
(> 5 ng/L) presented with elevated CS levels compared to women with undetectable levels; 1423 ± 272.5 vs 1347 ± 297.9
(p = 0.02). An opposite trend was observed in men. Metabolic dysfunction parameters were also associated with CS
elevation in both men and women.
Conclusions: Parasympathetic dysfunction assessed by total serum cholinesterase activity predicts hemodynamic
changes during exercise. CS is also associated with hs-cTnT detection in women and inversely so in men. Future
studies to assess the potential clinical use of this new sex-specific biomarker in cardiovascular disease risk stratification
are warranted.
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Background
Imbalanced autonomic nervous system (ANS) activity is
associated with poor cardiovascular outcome (Lahiri et al.
2008). More specifically, decreased parasympathetic activ-
ity has been related to metabolic impairment, systemic in-
flammation and future major adverse cardiovascular
events (MACE) (Shenhar-Tsarfaty et al. 2014; Rao et al.
2007; Hansen et al. 2017). However, clinically validated
biomarkers to assess the parasympathetic system are not
yet available and the main neurotransmitter-acetylcholine
(ACh) is extremely labile and difficult to measure in the
circulation. Therefore, the use of its hydrolyzing enzymes
as an indirect measurement for parasympathetic dysfunc-
tion could serve as a surrogate marker in many clinical
settings (Shenhar-Tsarfaty et al. 2014). Our method uses
the ACh analog acetylthiocholine (ATCh) as a substrate
that is hydrolyzed by both ACh degrading enzymes
(acetylcholinesterase and butyrylcholinestersase) and re-
flects the total serum capacity for ACh hydrolysis, referred
to as cholinergic status (CS).
Traditional non-invasive parameters of ANS dysfunc-
tion e.g. heart rate and blood pressure profile during exer-
cise are predictors of worse cardiovascular prognosis
(Lahiri et al. 2008; Jouven et al. 2005). Specifically, an ex-
aggerated blood pressure response to exercise is associated
with a greater risk of developing hypertension and in-
creased prevalence of left ventricular hypertrophy in
otherwise normotensive adults (Kim and Ha 2016). How-
ever, indications to start treatment based on these parame-
ters, and the prognostic value of such interventions are
inconclusive (Kim and Ha 2016; Chant et al. 2018).
High sensitive cardiac troponin T (hs-cTnT) could po-
tentially aid in cardiovascular disease (CVD) risk stratifica-
tion among individuals presenting with abnormal heart rate
and blood pressure profile during exercise. hs-cTnT is re-
lated to future cardiovascular events in the general popula-
tion and in patients with ischemic heart disease, with
recent reports demonstrating evident structural changes in
CVD-free adults with elevated concentrations (Willeit et al.
2017; Seliger et al. 2017). Of note, recent reports highlight-
ing sex- and gender-related differences in circulating bio-
markers of CVD call for a more gender-oriented clinical
and research approach (Daniels and Maisel 2015).
Therefore, we sought to examine the relationship be-
tween total serum cholinesterase activity and hs-cTnT
alongside traditional hemodynamic parameters of ANS
function during exercise. We aimed to evaluate our novel
biomarker in a cohort of apparently healthy individuals
and to determine sex- and gender-related differences.
Methods
Study population
We enrolled 1526 individuals (mean age 49 ± 11 yr., 75%
men) from the Tel Aviv Medical Center Inflammation
Survey (TAMCIS). TAMCIS encompasses a large cohort
of apparently healthy subjects who attend the Tel Aviv
Medical Center for routine annual checkups. These in-
clude a physician’s interview and examination, blood and
urine tests, and a cardiac exercise ECG stress test (EST).
Participants were enrolled consecutively between February
2016 and June 2017. Patients between the age of 18–90
were included in the study. Participants’ characteristics as
well as information on cardiovascular co-morbidities are
shown in Table 1. The study was approved by the local
ethics committee, conformed to the principles outlined in
the Declaration of Helsinki, and informed consent was
Table 1 Population Characteristics by Sex





Age, years 50 (11) 47 (12) 0.001
BMI, Kg/m2 27 (4) 25 (5) < 0.001
Resting Pulse, beats/min 69 (14) 74 (11) 0.002
Systolic BP, mmHg 130 (16) 119 (20) < 0.001
Diastolic BP, mmHg 80 (34) 73 (12) 0.001
Peak systolic BP, mmHg 173 (23) 156 (23) < 0.001
Peak diastolic BP, mmHg 72 (13) 70 (13) 0.091
METs 12 (2) 10 (6) < 0.001







hs-cTnT, ng/L 5 [3a,7] 3.0 [3a,4] < 0.001
Fasting glucose, mg/dl 89 (14) 84 (9) < 0.001





T-C, mg/dl 186 (33) 192 (33) 0.004
HDL-C, mg/dl 47 (12) 61 (15) < 0.001
LDL-C, mg/dl 115 (28) 111 (28) 0.032
TG, mg/dl 121 (65) 100 (49) < 0.001
eGFR, mL/min/1.73m2 94 (14) 100 (15) < 0.001
UACR, mg/g 2 [1, 4] 3 [2, 7] < 0.001
hs-CRP, mg/l 2 (2.9) 2.7 (3.7) < 0.001
Diabetes diagnosis (%) 62 (7) 8 (3) 0.016
Hypertension (%) 182 (17) 32 (9) < 0.001
IHD diagnosis (%) 53 (6) 13 (5) 0.470
Use of antihypertensive- medication
(%)
134 (12) 17 (5) < 0.001
Hyperlipidemia (%) 97 (9) 25 (7) 0.307
BP blood pressure, BMI body mass index, METs Metabolic equivalents; hs-cTnT
high sensitive cardiac troponin T, HbA1c Hemoglobin A1C, T-C total cholesterol,
HDL-C high density lipoprotein cholesterol, LDL-C low density lipoprotein
cholesterol, TG triglycerides, eGFR estimated glomerular filtration rate, UACR
urinary albumin/creatinine ratio, hs-CRP high sensitive C- reactive protein, IHD
ischemic heart disease. Values are mean (SD) or median [interquartile range]
a Equivalent to non-detectable hs-cTnT (below detection level of 5 ng/L), as
described in the Methods section
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obtained from all participants as detailed in previous re-
ports (Brzezinski et al. 2018; Brzezinski et al. 2017).
We collected blood samples for the measurement of
multiple physiologic and metabolic parameters including
hs-cTnT, lipid profile, glucose, hemoglobin A1c
(HbA1C) and CS levels. Blood samples were obtained at
rest before the participants performed the EST.
Cholinergic status measurement
Sympathetic-parasympathetic balance was assessed as
previously described by our group (Shenhar-Tsarfaty et
al. 2014). We used the ACh analog acetylthiocholine
(ATCh) as a substrate that is hydrolyzed by both ACh
degrading enzymes (acetylcholinesterase and butyrylcho-
linestersase) and reflects the total serum capacity for
acetylcholine hydrolysis, referred to as CS.
Serum samples were frozen at − 80 °C until acetylcho-
line hydrolysis analysis. Acetylcholinesterase and total
cholinesterase activity levels were assayed in triplicates
in a microtiter plate using an adaptation of the Ellman
assay (ELLMAN et al. 1961). Hydrolysis of 1 mM acet-
ylthiocholine (ATCh, Sigma) was followed by spectroflu-
orometry (Spectrafluor Plus, Tecan) at 405 nm. Prior to
read, we incubated the samples for 20 min in the dark
with (for acetylcholinesterase activity) or without (for
total cholinesterase activity) 50 μM tetra isopropyl pyro-
phosphoramide (iso-OMPA, Sigma) which is a specific
butyrylcholinestersase inhibitor.
We calculated enzyme activity using 13,600M/cm as
the e405 for 5-thio-2-nitrobenzoate. Total cholinergic
activity is termed CS (Shenhar-Tsarfaty et al. 2015). The
calculated coefficient of variation varies from 3 to 13%
depending on the tested cohort (minimal with control,
varying with acute phase patients such as those with
myocardial infarction or stroke); the intra assay is 6.75%,
enabling good discrimination between the groups.
Exercise-hemodynamic parameters
All subjects performed an EST according to the Bruce
protocol. The test was operated by a trained technician and
the results were analyzed on the spot by a cardiologist.
A hypertensive reaction during exercise was consid-
ered as values above the 90th percentile cutoff of peak
systolic blood pressure (SBP) values; > 205 mm/Hg in
men and > 187 mm/Hg in women. These values are simi-
lar to previous study populations (Kim and Ha 2016;
Lewis et al. 2008). SBP elevation rate was calculated as
peak SBP minus SBP at rest divided by time (in min) to
peak. Heart rate recovery rate was calculated as absolute
values of heart rate upon recovery minus peak rate di-
vided by the recovery time (min). Men and women were
divided into sex-specific quartiles, starting with individ-
uals with low heart rate recovery rate at the bottom
quartiles and ones with fast recovery rates at the top
quartiles.
Measurement of high-sensitive cardiac troponin T and
other metabolic parameters
hs-cTnT was measured using a sandwich immunoassay
method with a Roche Elecsys 2010 Analyser (Roche
Diagnostics). The range of the assay is 3–100,000 ng/L
with levels below limit of blank (levels that are not
measurable and are recorded as blank) of 3 ng/L. (Agar-
wal et al. 2011) Of note, hs-cTnT levels between 3 and
5 ng/L are measurable but with lower precision than
concentrations ≥5 ng/L. (Saunders et al. 2011; McEvoy
et al. 2016) Thus, 5 ng/L is the limit of detection of this
assay and was used as the cut-off for our detectable
hs-cTnT category. Levels of 14 ng/L or greater repre-
sented the 97th percentile in the TAMCIS study sample
and the 99th percentile value for a healthy reference
group aged 20–70 years (Giannitsis et al. 2010).
We separated A1c from non-glycated hemoglobin of
whole blood samples in EDTA with Tosoh’s G7 HPLC
(Tosoh Bioscience, Inc. San Francisco, CA, USA). HbA1c
levels were categorized as: healthy- < 5.7%; pre-diabetic -
5.7–6.4%; and diabetic - > 6.5%, according to the American
Diabetes Association guidelines (Care and Suppl 2018)..
Evaluation and diagnosis of metabolic syndrome (and its
components) were performed based on the joint interim
statement of the International Diabetes Federation Task
Force on Epidemiology and Prevention; National Heart,
Lung, and Blood Institute; American Heart Association;
World Heart Federation; International Atherosclerosis So-
ciety; and International Association for the Study of Obes-
ity (Alberti et al. n.d.). Briefly, elevated waist
circumference was defined as ≥102 cm in men and ≥ 80
cm in women, as recommended for individuals of Euro-
pean and Middle Eastern descent. Elevated triglycerides
were defined as ≥150mg/dl (1.7mmol/l) or on drug treat-
ment for elevated triglycerides. Reduced high-density
lipoprotein-cholesterol (HDL) was defined as < 40mg/dl
(1.0mmol/l) in men and < 50mg/dl (1.3mmol/l) in
women. Elevated blood pressure was defined as ≥130
mmHg for SBP or ≥ 85mmHg for diastolic blood pres-
sure, or on antihypertensive drug treatment in a patient
with a history of hypertension. Elevated fasting glucose
was defined as ≥100mg/dl (5.55mmol/l). The diagnosis of
metabolic syndrome was based on the existence of at least
three abnormal findings out of the five mentioned above.
Statistical analysis
All continuous variables are displayed as means (SD) for
normally distributed variables or median [interquartile
range] for variables with abnormal distribution. Categor-
ical variables are displayed as numbers (%) of subjects
within each group. The different biomarkers in men and
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women were compared by a Student’s t test for normally
distributed variables and by the Mann-Whitney U test
for non-normally distributed ones. To assess associations
among categorical variables, we used a chi-square test.
We performed a one-way Analysis of Variance (ANOVA)
with a linear contrast to compare the CS values between
sex-specific quartiles of heart recovery. A Student’s t test
was used to compare CS values between the different bin-
ary variables, i.e. subjects with a normal vs hypertensive re-
action during exercise, healthy vs. pre-diabetic individuals
and subjects with detectable vs. non-detectable hs-cTnT.
In order to identify possible confounders, we performed a
multivariate regression aimed to predict a hypertensive reac-
tion during exercise. The model was controlled for the follow-
ing covariates: categorized sex-specific quartiles of CS, age,
body mass index (BMI), systolic and diastolic blood pressure
at rest and metabolic equivalents (METs). Pearson’s test was
used to assess the correlation between CS values and SBP ele-
vation rate. Spearman’s test was used to assess the correlation
between CS values and hs-cTnTconcentrations.
A one-way ANOVA was used to evaluate the difference
in BMI and the number of metabolic syndrome compo-
nents between the different sex-specific quartiles of CS
values. A multivariate regression was used to predict de-
tectable hs-cTnT status (> 5 ng/L) with the following co-
variates: age (in years), number of metabolic syndrome
components and sex-specific quartiles of CS values.
P values of < 0.05 were considered statistically signifi-
cant. We used the R statistical package (version 3.3.1, R
Foundation for Statistical Computing, Vienna, Austria)
along with IBM SPSS Statistics 22.0 statistical package
(IBM Corporation, Armonk, New York, USA) and
GraphPad Prism version 7.00 (GraphPad Software, La
Jolla, CA, USA) for all statistical analysis.
Results
Participants’ characteristics are shown in Table 1. Men
had a higher prevalence of hypertension and diabetes
along with slightly higher BMI, glucose and blood lipids
levels. Among 1526 participants, 144 demonstrated a
hypertensive reaction during exercise (~ 9% for both
men and women).
CS at rest predicts hemodynamic parameters during
exercise
Concordant with previous reports, overall CS values
were lower in women compared to men (Table 1) (Arbel
et al. 2014).
CS values at rest predicted multiple exercise-
hemodynamic changes in a sex-dependent manner, dem-
onstrating significant trends in women rather than men.
In women, heart rate recovery after exercise was in-
versely correlated to CS values, with decreasing levels
evident between heart rate recovery quartiles (Fig. 1).
Furthermore, a hypertensive reaction during exercise
was associated with elevated CS values; 1506 ± 277.1 for
mean ± SD in hypertensives vs. 1356 ± 290.1 in normo-
tensive women (p = 0.003, Fig. 2). This finding remained
significant after controlling for age, BMI, systolic and
diastolic blood pressure at rest and METs (Table 2).
CS was also correlated with the SBP elevation rate; r =
0.2, p = 0.001, suggesting this biomarker reflects upon
arterial vasoconstriction in normal and hypertensive
adult women (Fig. 2).
CS elevation is associated with metabolic impairment
Next, we sought to examine whether elevated CS values
also correlate with metabolic impairment. HbA1c levels
in women were significantly correlated with CS values; r
= 0.18, p < 0.001. Also, pre-diabetic women (HbA1C >
5.7%) presented higher CS values than healthy ones;
1447.8 ± 296.8 vs. 1355.58 ± 289.711 for mean ± SD re-
spectively (p = 0.03).
Trend analysis revealed elevated BMI and accumulat-
ing components of the metabolic syndrome across
sex-specific quartiles of CS in both men (p for trend =
0.019, 0.046) and women (p for trend = 0.018, < 0.001).
Fig. 1 CS values decrease between sex-specific quartiles of heart rate recovery from exercise. Women (left) and Men (right) were divided into quartiles
according to pulse recovery from exercise rate (beats/min). CS values represent total serum rates of ATCh hydrolysis (substrate hydrolyzed per minute
per milliliter). CS values were inversely correlated to heart rate recovery from exercise in both women and men (p for trend < 0.01, = 0.03 respectively).
Presented are mean ± SEM. p by one-way ANOVA with a linear contrast for trend analysis. ATCh – Acetylthiocholine; CS - Cholinergic status
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CS is positively associated with hs-cTnT detection in
women and inversely so in men
Finally, and most importantly, we aimed to evaluate
sub-clinical myocardial damage through the use of circu-
lating hs-cTnT. Interestingly, opposite trends were ob-
served between the sexes. Detectable hs-cTnT in women
was correlated with elevated CS levels; 1423 ± 272.5 for
mean ± SD in women with detectable hs-cTnT (> 5 ng/
L) vs 1347 ± 297.9 in undetectable subjects (p = 0.02,
Fig. 3). In contrast, men with detectable circulating car-
diac troponin presented lower levels of CS compared
with men with undetectable levels (p = 0.03, Fig. 3). CS
and hs-cTnT demonstrated a weak yet significant linear
correlation. This correlation was also sex specific; posi-
tive in women (r = 0.1, p = 0.047) and negative in men (r
= − 0.1, p = 0.001).
Multivariate analysis adjusted for age and metabolic
profile (defined as number of metabolic syndrome com-
ponents), revealed that elevated CS values predicted un-
detectable hs-cTnT status in men compared to
detectable status in women, albeit not statistically signifi-
cant in women (Fig. 4). Age was identified as a signifi-
cant predictor in the model for both sexes. Of note, after
controlling for age, CS remained a significant predictor
for hs-cTnT detection in men but not in women (Fig. 4,
Additional file 1: Table S1). CS and hs-cTnT elevation
might be associated with the aging female. The number
of metabolic syndrome components was associated with
hs-cTnT detection in both sexes (Fig. 4, Additional file 1:
Table S1), similar to previous findings (Milwidsky et al.
2014; Pokharel et al. 2017).
Discussion
The main finding of this study is the positive association
between serum cholinesterase activity (CS values) and
hs-cTnT detection in women rather than men (Fig. 5).
To our knowledge, this marks the first attempt to de-
scribe the interaction between ANS dysfunction and
hs-cTnT elevation in apparently healthy individuals.
Sex-related differences in circulatory biomarkers for
CVD risk stratification are becoming increasingly rele-
vant. hs-cTnT levels are generally lower in women com-
pared to men, at both baseline and in the setting of
acute coronary syndrome (Daniels and Maisel 2015).
The exact reason remains elusive but might relate to the
smaller cardiac mass in females. The positive association
between CS and hs-cTnT detection seen in women ra-
ther than men call for future mechanistic understanding
A
B
Fig. 2 Cholinergic Status correlates with blood pressure elevation during exercise in women but not in men. a CS values are higher in women with a
hypertensive reaction during exercise (defined as SBP > 187mm/Hg in women (left) and > 205mm/Hg in men (right)). b CS values in women correlate
with SBP elevation rate (r= 0.2, p= 0.001) calculated as peak SBP minus SBP at rest divided by time to peak. CS values represent total serum rates of ATCh
hydrolysis (substrate hydrolyzed per minute per milliliter). Presented are mean ± SEM. p by student’s T-test (a) and Pearson’s correlation test (b). SBP -
Systolic blood pressure; ATCh - Acetylthiocholine; CS – Cholinergic status
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of ANS dysfunction and myocyte injury in the female
heart. Decreased parasympathetic activity, measured
here as elevated values of CS, is also associated with a
systemic pro-inflammatory state (Shenhar-Tsarfaty et al.
2014; Shenhar-Tsarfaty et al. 2016), suggesting a possible
cause for cardiac necrosis and structural changes evident
as detectable hs-cTnT levels. We hypothesize that
low-grade systemic inflammation leads to more elevated
levels of CS in women rather than men, possibly
explaining the sex-related difference seen in the associ-
ation between hs-cTnT detection and CS values. Our
findings, along with previous well-established reports on
hs-cTnT elevation and future risk for MACE (Willeit et
al. 2017; Seliger et al. 2017), place this novel biomarker
in a significant clinical perspective, especially among
women.
In women, the association between CS and hs-cTnT
detection was not statistically significant after controlling
for age. However, CS remained inversely correlated with
hs-cTnT in men. It is possible that menopausal status is
involved in the regulation of CS and hs-cTnT and is thus
responsible for this sex-related difference. Future studies
aimed at assessing the influence of sex hormones on CS
throughout women’s life-span are needed.
Our sex-specific thresholds for CS values and
hemodynamic parameters of exercise promote the idea
of implying more sex-specific thresholds for biomarkers
in both research and clinical settings of CVD. Future de-
velopment of the high sensitivity assay for cardiac tropo-
nin will enable these specific thresholds also for
apparently healthy individuals who present with rela-
tively low circulatory concentrations.
The association between CS values and hemodynamic
changes during an EST contributes additional insight
into the multifactorial etiology of exaggerated blood
pressure response during exercise (Kim and Ha 2016).
Serum cholinesterase activity seems to be an important
contributor, placing ANS dysfunction as a potential
therapeutic target to treat hypertension.
Recent reports have demonstrated that pharmaceutical
parasympathetic stimulation with cholinesterase inhibi-
tors (e.g. pyridostigmine, donepezil, etc.) is effective in
both left and right heart failure, alongside associated
pulmonary and systemic arterial hypertension in
Table 2 Multivariate regression to predict a hypertensive reaction during exercise in women and men
Covariates Women Men











CS (1st quartile) .221 .474
CS (2nd quartile) 3.717 .145 .635 21.762 .976 .942 .510 1.868
CS (3rd quartile) 4.701 .090 .785 28.142 1.492 .210 .798 2.791
CS (4th quartile) 6.301 .037 1.116 35.575 1.282 .438 .684 2.402
Age (years) 1.043 .058 .999 1.090 .998 .871 .977 1.020
BMI 1.083 .095 .986 1.188 1.102 .001 1.041 1.166
Systolic BP at rest 1.065 .000 1.031 1.099 1.068 .000 1.050 1.086
Diastolic BP at rest 1.011 .646 .965 1.058 .988 .317 .966 1.011
METs .956 .705 .759 1.205 1.065 .218 .964 1.177
OR odds ratio, CI confidence intervals, CS cholinergic status, BMI body mass index, BP blood pressure, METs Metabolic equivalents
Fig. 3 CS values are higher in women with detectable hs-cTnT (> 5 ng/L) than in women with undetectable levels. CS values represent total
serum rates of ATCh hydrolysis (substrate hydrolyzed per minute per milliliter). An opposite trend was observed in men. Presented are mean ±
SEM. p by Student’s T- test. hs-cTnT - High sensitive cardiac troponin T; ATCh – Acetylthiocholine; CS – Cholinergic status
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experimental models and humans (Okazaki et al. 2010;
da Silva Gonçalves Bos et al. 2017). We present here a
relatively accurate and clinically-applicable method to
monitor these new therapeutic strategies, potentially
helping to integrate them into future clinical practice.
Future studies on the effects of these interventions on
CS are warranted.
Our study is limited by the lack of follow-up data on
the prevalence of MACE in our cohort, thus limiting the
prognostic evaluation of this new biomarker. Future lar-
ger studies with adequate follow-up periods are needed
in order to determine whether CS measurements can
provide additional prognostic value to existing bio-
markers of CVD, in either healthy adults or in
Fig. 4 Sex difference in CS prediction of hs-cTnT detection. We performed a multivariate logistic regression to predict detectable hs-cTnT status (> 5 ng/L)
with the following covariates: age (in years), number of metabolic syndrome components and sex-specific quartiles of CS values. CS was correlated with
hs-cTnT detection in women, albeit not statistically significant (OR = 1.05, p= 0.6). This correlation is inversed in men (OR = 0.8, p< 0.001). Presented are
odds ratio (OR) with 95% confidence intervals (CI). hs-cTnT - High sensitive cardiac troponin T; MetS - Metabolic syndrome; CS – Cholinergic status
Fig. 5 Summary Figure.The acetylcholine analog acetylthiocholine is hydrolyzed by two degrading enzymes (acetylcholinesterase and
butyrylcholinestersase). Its degredation reflects the total serum cholinesterase activity referred to as Cholinergic Status (CS). CS potentially
reflects upon the body’s sympathetic-parasympathetic balance with decreased levels of CS indicating prominent parasympathetic activity.
In both sexes, CS was correlated with age and metabolic impairment. In women, elevated CS values predicted a hypertensive reaction
during exercise and correlated with systolic blood pressure elevation rate. Most importantly, CS is positively correlated with high sensitive
cardiac troponin T detection in women but inversely so in men. Heart rate recovery from exercise was inversely correlated to CS in both
sexes, more significantly in women. CS is a potential new biomarker for cardiovascular disease risk stratification, autonomic nervous
system function and monitoring of parasympathetic stimulation treatment strategies. ANS- Autonomic Nervous System
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individuals with existing co-morbidities. Furthermore,
the observational nature of our findings limits our ability
to determine causality between CS and hs-cTnT eleva-
tion. The significant trends presented here in a relatively
large sample of patients call for future experimental
studies to determine the underlying mechanism for
changes in CS levels in both males and females. Of note,
our study population consists largely of male partici-
pants (75%), thus potentially affecting data interpret-
ation. However, the female group still consists of a
relatively large number of observations (n = 373) and all
statistical analysis was performed separately in men and
women with the use of sex-specific thresholds.
Conclusions
We conclude that CS is able to predict multiple
hemodynamic changes during exercise, especially in
women. CS values demonstrate opposite trends between
men and women regarding its association with the de-
tection of circulating cardiac troponin. CS is a potential
biomarker for decreased parasympathetic activity and
ANS dysfunction. Its relatively rapid, accurate and ap-
plicable nature, calls for further investigation of its use
in clinical settings of CVD risk stratification in the gen-
eral population, especially in women.
Additional file
Additional file 1: Table S1. Multivariate Regression to Predict hs-cTnT
Detection Status (> 5 ng/L) in Men and Women. (DOCX 19 kb)
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